Combining Epigenetic and Immunotherapy to Combat Cancer

被引：244

作者：

Chiappinelli, Katherine B. ^{[1
]}

Zahnow, Cynthia A. ^{[1
]}

Ahuja, Nita ^{[1
]}

Baylin, Stephen B. ^{[1
]}

机构：

[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA

来源：

CANCER RESEARCH | 2016年 / 76卷 / 07期

关键词：

HISTONE DEACETYLASE INHIBITORS; CELL LUNG-CANCER; OVARIAN-CANCER; DNA METHYLATION; CTLA-4; BLOCKADE; ENDOGENOUS RETROVIRUSES; IMMUNOMODULATORY ACTION; INTERFERON RESPONSE; GENE-EXPRESSION; IMMUNE EVASION;

D O I：

10.1158/0008-5472.CAN-15-2125

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most exciting recent advance for achieving durable management of advanced human cancers is immunotherapy, especially the concept of immune checkpoint blockade. However, with the exception of melanoma, most patients do not respond to immunotherapy alone. A growing body of work has shown that epigenetic drugs, specifically DNA methyltransferase inhibitors, can upregulate immune signaling in epithelial cancer cells through demethylation of endogenous retroviruses and cancer testis antigens. These demethylating agents may induce T-cell attraction and enhance immune checkpoint inhibitor efficacy in mouse models. Current clinical trials are testing this combination therapy as a potent new cancer management strategy.

引用

页码：1683 / 1689

页数：7

共 76 条

[61] Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. [J].

Stresemann, C ;

Brueckner, B ;

Musch, T ;

Stopper, H ;

Lyko, F .

CANCER RESEARCH, 2006, 66 (05) :2794-2800

[62] LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4 [J].

TIVOL, EA ;

BORRIELLO, F ;

SCHWEITZER, AN ;

LYNCH, WP ;

BLUESTONE, JA ;

SHARPE, AH .

IMMUNITY, 1995, 3 (05) :541-547

[63] Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy [J].

Topalian, Suzanne L. ;

Drake, Charles G. ;

Pardoll, Drew M. .

CANCER CELL, 2015, 27 (04) :450-461

[64] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Carvajal, Richard D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Horn, Leora ;

Drake, Charles G. ;

Pardoll, Drew M. ;

Chen, Lieping ;

Sharfman, William H. ;

Anders, Robert A. ;

Taube, Janis M. ;

McMiller, Tracee L. ;

Xu, Haiying ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Agrawal, Shruti ;

McDonald, Daniel ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Wigginton, Jon M. ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454

[65] Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells [J].

Tsai, Hsing-Chen ;

Li, Huili ;

Van Neste, Leander ;

Cai, Yi ;

Robert, Carine ;

Rassool, Feyruz V. ;

Shin, James J. ;

Harbom, Kirsten M. ;

Beaty, Robert ;

Pappou, Emmanouil ;

Harris, James ;

Yen, Ray-Whay Chiu ;

Ahuja, Nita ;

Brock, Malcolm V. ;

Stearns, Vered ;

Feller-Kopman, David ;

Yarmus, Lonny B. ;

Lin, Yi-Chun ;

Welm, Alana L. ;

Issa, Jean-Pierre ;

Minn, Il ;

Matsui, William ;

Jang, Yoon-Young ;

Sharkis, Saul J. ;

Baylin, Stephen B. ;

Zahnow, Cynthia A. .

CANCER CELL, 2012, 21 (03) :430-446

[66] Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma [J].

VanderMolen, Karen M. ;

McCulloch, William ;

Pearce, Cedric J. ;

Oberlies, Nicholas H. .

JOURNAL OF ANTIBIOTICS, 2011, 64 (08) :525-531

[67] Manipulation of B-cell responses with histone deacetylase inhibitors [J].

Waibel, Michaela ;

Christiansen, Ailsa J. ;

Hibbs, Margaret L. ;

Shortt, Jake ;

Jones, Sarah A. ;

Simpson, Ian ;

Light, Amanda ;

O'Donnell, Kristy ;

Morand, Eric F. ;

Tarlinton, David M. ;

Johnstone, Ricky W. ;

Hawkins, Edwin D. .

NATURE COMMUNICATIONS, 2015, 6

[68] Transcription of IAP endogenous retroviruses is constrained by cytosine methylation [J].

Walsh, CP ;

Chaillet, JR ;

Bestor, TH .

NATURE GENETICS, 1998, 20 (02) :116-117

[69] Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model [J].

Wang, Lei ;

Amoozgar, Zohreh ;

Huang, Jing ;

Saleh, Mohammad H. ;

Xing, Deyin ;

Orsulic, Sandra ;

Goldberg, Michael S. .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (09) :1030-1041

[70] LYMPHOPROLIFERATIVE DISORDERS WITH EARLY LETHALITY IN MICE DEFICIENT IN CTLA-4 [J].

WATERHOUSE, P ;

PENNINGER, JM ;

TIMMS, E ;

WAKEHAM, A ;

SHAHINIAN, A ;

LEE, KP ;

THOMPSON, CB ;

GRIESSER, H ;

MAK, TW .

SCIENCE, 1995, 270 (5238) :985-988

← 1 2 3 4 5 6 7 8 →